ERBB2 and breast cancer: In this study we compared the prognostic significance of Ki-67 LIs obtained by two methods the hot spot method and the average method, in hormone receptor-positive, HER2-negative breast cancers, to determine which of the methods had better sensitivity and specificity for predicting patients’ prognosis.